This Week at FDA: New Guidance, Shutdown Pay Issues, and Another Inspection OverhaulOctober 24, 2025October 25, 2025
FDA’s Drug and Biologics Centers Report Steep Drop in Headcount in FY 2025October 22, 2025October 25, 2025
This Week at FDA: Lawmakers Look to Fund FDA, HHS’ Shutdown RIF, and MoreOctober 16, 2025October 18, 2025
This Week at FDA: More Layoffs at HHS, Prasad’s CBER Hires, and Peter Marks Joins Eli LillyOctober 10, 2025October 14, 2025
This Week at FDA: ANDA Prioritization Pilot, CDRH Guidance Priorities, and MoreOctober 3, 2025October 4, 2025
This Week: FDA Revokes LDT Rule, Monarez Warns About Vaccine Policies, Kennedy Called to Defend His DecisionsSeptember 19, 2025September 19, 2025
This Week at FDA: FDA’s Ad Crackdown, Abandoning AdComms, and MoreSeptember 12, 2025September 15, 2025
